Allelic Dropout, Peak Height Balance and Low-Template DNA Interpretation

Explore allelic dropout, stochastic PCR variation and peak-height imbalance in low-template forensic STR profiles, with five worked examples, replicate analysis, mixture challenges and validated interpretation guidance.

33 Min Read
#image_title

Allelic dropout and peak-height imbalance are among the most consequential challenges in interpreting low-template forensic DNA profiles. A stain may contain DNA from a particular person, yet an allele can fail to appear above the laboratory’s analytical detection criterion. At another locus, both alleles may be visible but very unequal in height. Such results can resemble homozygous genotypes, minor contributors or incomplete profiles and can affect inclusion, exclusion and statistical evaluation.

The central principle is that low-template DNA interpretation is a problem of uncertainty, not merely low RFU. Analysts must distinguish what was observed from what may have been missed, account for stochastic PCR variation and use methods validated for the quantity and quality of the evidence. This study guide focuses on practical decisions, five worked examples, replicates, peak-height balance and statistical treatment of dropout. For prerequisite topics, see Simply Forensic’s electropherogram interpretation guide, analytical and stochastic threshold guide and mixture interpretation guide.

KEY LEARNING POINTS

  • There is no single DNA mass or peak-height cut-off that defines every low-template profile.
  • Low heterozygote peak-height ratio (PHR) is evidence of imbalance, not a diagnosis of its cause.
  • Non-detection is an observation; dropout is one possible biological or analytical explanation.
  • A high shared peak in a DNA mixture can conceal an undetected allele from a low-level contributor.
  • Replicate testing and probabilistic genotyping can help evaluate uncertainty, but neither guarantees complete recovery of the true genotypes.

What does low-template DNA mean?

Low-template DNA (LT-DNA) describes samples or individual contributions for which limited effective template molecules produce consequential stochastic variation. The older term low-copy-number (LCN) DNA has sometimes referred either to small amounts of input DNA or to enhanced-sensitivity methods, such as an increased number of PCR cycles. Historical teaching often mentioned less than 100 pg or 200 pg as examples, but there is no universally valid boundary separating ordinary from low-template interpretation. Gill and Buckleton specifically argued against relying on a single definition of low-copy-number DNA (2010 study).

Effective template availability depends on quantity, sample quality, the fraction placed into PCR, assay design and competing contributors. A mixed specimen might have ample total human DNA while its minor contributor provides very little usable template. Conversely, a low measured concentration does not by itself demonstrate that every locus has experienced dropout. Quantification data, including degradation and inhibition indicators, inform the interpretation but cannot reveal precisely how many intact molecules were sampled for each allele. See the real-time PCR quantification guide.

Why low template causes stochastic PCR effects

For an ordinary diploid heterozygote, each allele has a limited number of initial copies in a very small DNA aliquot. During aliquoting, some allele-bearing molecules may not enter the reaction at all. In early PCR cycles, the few molecules that enter may amplify at different rates by chance. Once one allele has an early advantage, later cycles can magnify that difference. These random sampling processes are called stochastic effects.

Timken and colleagues examined dilution series and demonstrated that, as template quantity decreases, heterozygote imbalance and allele non-detection become more frequent. Their findings support the importance of pre-PCR molecular sampling in low-template behaviour (Forensic Science International: Genetics, 2014). Sample degradation, PCR inhibition and allele-specific amplification efficiency can produce related or overlapping patterns.

Three outcomes should be distinguished: peak-height imbalance when two alleles are detected at unequal heights; allelic dropout when one allele truly present fails the qualifying detection criterion; and locus dropout when none of the contributor’s alleles at a locus are detected. An electropherogram may show one outcome at one locus and a different outcome at another.

Peak-height balance: calculating and interpreting PHR

When a heterozygous genotype can reasonably be assigned to a single contributor, the peak-height ratio compares the shorter and taller peaks by fluorescence height:

PHR (%) = [lower heterozygote peak height (RFU) ÷ higher heterozygote peak height (RFU)] × 100.

This formulation returns values between 0% and 100% for two detected positive peak heights. A ratio near 100% indicates similar measured peak heights; a smaller value indicates greater imbalance. However, there is no universal percentage at which a heterozygote becomes invalid or a mixture becomes proven. Kelly and colleagues modelled heterozygote balance and showed that its variability depends on the magnitude of the observed signals (2012 study). Laboratories must establish suitable expectations from their own data.

Synthetic locusPeak APeak BCalculationWhat the ratio means
Well-balanced pair820 RFU700 RFU700 / 820 × 100 = 85.4%Moderate-to-good numerical balance in this illustration
Pronounced imbalance260 RFU92 RFU92 / 260 × 100 = 35.4%Marked numerical imbalance; cause not identified
Composite mixture peak310 RFU690 RFU310 / 690 × 100 = 44.9%Not a valid individual PHR if 690 RFU represents shared alleles

A low ratio can arise from limited template, inhibition, degradation, locus-specific amplification bias, a true mixture or an incorrectly assigned genotype. It does not independently decide among them. A seemingly balanced pair does not prove the sample contains one person: two contributors may share alleles or produce coincident peaks.

Figure 1: from balanced alleles to possible non-detection

The following original teaching diagram shows different illustrative heterozygote observations. It is not a measured probability-of-dropout curve or a progression that every sample must follow.

FIGURE 1 · THREE SYNTHETIC PEAK-HEIGHT PATTERNS

A · Two balanced alleles

850 and 790 RFU
PHR = 92.9%

B · Unequal detected alleles

420 and 210 RFU
PHR = 50.0%

C · One detected allele

160 RFU; second allele not detected
PHR cannot be calculated

Original Simply Forensic bar schematics, not actual EPG traces. The dashed bar represents a possible undetected allele, not an observed signal. The three examples do not share a measured DNA input or provide a calibrated dropout risk.

Non-detection is an observation; dropout is an explanation

Non-detection means that a qualifying signal was not observed under the laboratory’s chosen detection criteria. Allelic dropout means that an allele actually present in the DNA source or template failed to yield a qualifying detected result. In a known-genotype validation sample, the analyst can compare the outcome with the true genotype and identify specific dropout events. In an unknown evidentiary sample, the analyst usually cannot directly observe which allele is missing; instead, the interpretation must assess whether dropout is plausible.

For example, a known validation sample with genotype 15,18 may show only allele 15 at 145 RFU. If 18 does not meet the validated detection criterion, allele 18 has dropped out in that test. In a questioned single-source-looking profile with only 15 visible, the observation could represent homozygote 15,15 or heterozygote 15,x with an undetected partner. That uncertainty cannot be resolved by inventing an allele or by calculating PHR with a missing value.

In low-template mixtures, allelic dropout can create misleading appearances of exclusion or apparent simplicity. The ISFG DNA Commission recommendations (2012) describe probabilistic methods for treating uncertainty arising from dropout and drop-in rather than relying exclusively on rigid present/absent judgments.

What causes missing alleles besides low DNA quantity?

Potential causeMechanismHelpful observations
Stochastic molecular samplingVery few target copies enter or amplify early in PCRReduced balance, sporadic allele detection, replicate variability
DNA degradationFragmentation compromises amplifiable targetsRelative loss of larger amplicons, high degradation index, partial profile
PCR inhibitionSample constituents reduce amplification efficiencyLow signal or irregular amplification; quantification and internal control findings
Primer-binding variationSequence differences interfere with primer annealingReproducible apparent null allele, possible recovery using another primer set
Detection and analytical settingsFluorescence remains below the validated reporting/detection levelNon-qualifying signal may be visible in raw data but not accepted as a called allele
Whole-locus failureNeither allele meets criteria for the locusMissing locus; interpretation depends on sample quality and assay performance

These are potential explanations rather than unique signatures. In particular, a primer-binding-site variant may cause a repeatedly missing allele despite adequate DNA input. NIST research on null and variant STR alleles highlights the importance of sequence-level investigation and testing with alternative primer locations in suitable circumstances. A repeated locus-specific absence should not automatically be blamed on low-template stochastic sampling.

Where analytical and stochastic thresholds fit

The analytical threshold (AT) helps identify signals distinguishable from validated baseline noise; the stochastic threshold (ST), in a suitable binary interpretation framework, informs the risk of an undetected sister allele. Neither is a universal RFU number, and a peak above AT may still be a stutter or another artefact. We discuss derivation and validation in our dedicated AT versus ST guide.

For the five examples below only, assume a hypothetical laboratory has an AT of 50 RFU and an ST of 200 RFU, using a validated binary approach where relevant. These teaching figures are arbitrary; they are not recommendations for your kit, instrument, software or jurisdiction.

Critically, a single observed peak above ST does not guarantee that allelic dropout is impossible in all settings. A peak in a mixture may comprise contributions from multiple people or stutter products. It cannot necessarily be used as the peak height for one contributor’s allele. SWGDAM’s 2021 autosomal STR interpretation guidelines specifically caution against simplistic application of an ST to mixed profiles.

Five worked examples: interpreting low-template STR results

All examples use synthetic peaks and the hypothetical AT and ST described earlier. They demonstrate interpretation logic, not universal acceptance criteria.

Example 1: a relatively balanced heterozygote

At a synthetic D8S1179 locus, assume credible alleles 12 and 14 are observed at 820 RFU and 700 RFU. Both exceed the teaching AT, and the PHR is 700 ÷ 820 × 100 = 85.4%. The data show a reasonably balanced pair for this illustration, but the height alone does not prove a single source. The full multi-locus pattern, controls and validated heterozygote expectations are needed.

Correct teaching conclusion: two allele positions are visible and relatively balanced in this illustrative locus. The ratio is a numerical description, not an independent statement about the identity or number of contributors.

Example 2: severe imbalance without observed dropout

At a synthetic D3S1358 locus, alleles 15 and 17 produce peaks of 260 RFU and 92 RFU. The PHR is 92 ÷ 260 × 100 = 35.4%. The second allele is above the hypothetical AT (50 RFU), so this is a two-allele observation with pronounced imbalance, not an example of observed allelic dropout.

If the genotype is not securely established, possibilities include a genuine low-template heterozygote, mixture information, assay effects, inhibition or data-classification error. The allele 17 signal cannot be discarded solely because its PHR is small. Nor does a 35.4% ratio establish an extra donor. Review all loci, artefacts and the laboratory’s validated PHR expectations. Research by Kelly et al. explains why a fixed PHR cutoff is an inadequate universal model.

Example 3: documented dropout in a known validation sample

A synthetic known-genotype sample contains alleles 15,18. It is amplified at low input. Only allele 15 reaches 145 RFU; no qualifying allele 18 peak appears above the teaching AT. Because the laboratory knows the source genotype, the missing 18 is an experimentally recognizable dropout event.

Do not calculate 0 ÷ 145 and report a PHR of 0% as though two peak heights had been measured. There are not two measured qualifying peaks. In ordinary evidentiary testing without a known genotype, the same trace would be an apparently single-allele locus in which dropout must be considered—not proof that a particular unobserved allele was present.

In a binary method, this single peak is also below the illustrative ST of 200 RFU, strengthening the need to evaluate possible sister-allele non-detection. Even if a measured peak were above ST, the procedure’s assumptions and sample context still matter.

Example 4: shared alleles distort apparent PHR in a mixture

Consider a synthetic two-contributor mixture. Contributor A has genotype 10,12, while contributor B has genotype 12,13. The accepted peaks are 10 = 310 RFU, 12 = 690 RFU and 13 = 295 RFU. The 12 signal is shared: its height reflects amplification from alleles at the same position contributed by both individuals.

Naïvely pairing 10 with 12 gives 310 ÷ 690 × 100 = 44.9%. That is a valid arithmetic ratio of two observed peak heights but not a valid individual heterozygote PHR for contributor A, because the 690-RFU signal is not attributable solely to A. Shared alleles and stutter overlap are central complications in mixture deconvolution; see Number of Contributors in Forensic DNA Mixtures.

FIGURE 2 · WHY A SHARED PEAK IS NOT A SINGLE-DONOR HEIGHT

Contributor A

10,12

Source information disclosed for teaching only

Contributor B

12,13

Both individuals carry 12

Observed at allele 12

690 RFU

One composite peak, not two separately measured donor peaks

Original Simply Forensic conceptual infographic. No individual peak contribution can be assigned from the 690-RFU total by simple subtraction; actual data require validated mixture analysis.

A similar problem occurs if one contributor’s low allele overlaps the stutter position of another person’s strong allele. A high composite peak can coexist with an undetected allele elsewhere in the minor contributor’s genotype. This is why an apparent peak above ST does not settle mixture dropout.

Example 5: three amplifications and a hypothetical consensus rule

In this synthetic validation example, the true genotype is 8,10. Three separate amplifications are performed. A second allele is missing in the first run but appears in the other two:

AmplificationAllele 8Allele 10Observed result
R1175 RFUNot detectedOnly allele 8 called
R2132 RFU71 RFUBoth alleles detected
R3149 RFU64 RFUBoth alleles detected

If, solely for teaching, the laboratory employed a validated 2-of-3 consensus rule, allele 8 would be retained (3/3 detections) and allele 10 retained (2/3 detections). In validation, allele 10 is known to be genuine even though it was not detected in R1. This rule is illustrative, not a recommended consensus policy. Different rules, evidence quantities and software approaches can produce different assessments.

A stringent consensus rule may remove sporadic extraneous alleles while also discarding real donor alleles that do not reproduce because of dropout. A more inclusive composite profile may retain additional true information but also more unexplained peaks. Cowen and colleagues studied this trade-off (2011).

Should analysts repeat the PCR for every low-template sample?

Replication can reveal variability across independent amplifications, but it is not automatically the optimal use of scarce DNA. Dividing a tiny extract into multiple aliquots can decrease the number of target molecules in each reaction, increasing the chance that a particular allele never enters an individual tube. A single reaction using more template may be more informative for some samples. A decision analysis by Gittelson, Steffen and Coble directly compared one analysis with two replicates (2016).

Laboratories should define when repeat amplification, re-extraction, reinjection or no rework is appropriate. A second CE injection of the same amplified product is not equivalent to an independent PCR replicate: it re-examines the amplicons already produced and cannot recover a target allele that was never amplified in the first place. All repeats and any allele-classification changes require documented review; inconsistent results do not automatically prove one run was erroneous.

Where validated probabilistic-genotyping software supports multiple replicates, the laboratory may evaluate the datasets jointly rather than first collapsing all observations into one consensus genotype. This must remain within the software and laboratory’s validated use, following SWGDAM’s 2025 probabilistic-genotyping guidance.

Binary interpretation versus probabilistic genotyping

Binary interpretation uses laboratory-defined criteria to decide which observed alleles or genotype possibilities are accepted and when incomplete data require qualification. Analytical thresholds, stochastic thresholds, stutter expectations and heterozygote-balance rules may be relevant. The method must be validated for the results being interpreted, especially if allelic dropout is possible.

Semi-continuous probabilistic genotyping generally models allele presence or absence and probabilities of dropout or drop-in without exploiting all relative peak-height information. Fully continuous approaches also use quantitative peak data, and may model peak-height variation, mixture proportions, stutter and dropout. Neither turns uncertain genotypes into proven identities. Different validated models may assign different weights to difficult low-template evidence.

ApproachInformation usedHandling stochastic uncertaintyImportant limitation
BinaryObserved alleles, validated suitability and decision rulesOften threshold and rule based; may support qualified comparisonsOverly rigid decisions can lose information or fail to represent uncertainty
Semi-continuous PGPresence/absence patterns and model parametersModels dropout and possibly drop-in probabilitiesDoes not ordinarily make full use of quantitative relative peak heights
Fully continuous PGAllele positions and peak-height dataModels quantitative stochastic effects and other parametersRequires validated parameters, diagnostics and adequate data quality

The likelihood ratio (LR) compares the probability of the DNA results under specified competing propositions; it is not the probability of guilt or proof of how DNA reached an item. Poorly supported contributor assumptions, unsuitable data or unverified software outputs remain problematic even when an LR can be calculated. See the Simply Forensic likelihood-ratio guide and the NIST 2024 scientific foundation review.

Figure 3: a practical low-template interpretation infographic

FROM AN UNUSUAL PEAK TO A DEFENSIBLE CONCLUSION

1 · Verify the run

Controls, sizing, raw data, peak detection and artefacts

2 · Check sample context

Quantity, degradation, inhibition and profile completeness

3 · Assess uncertainty

PHR, missing alleles, possible sharing and alternative explanations

4 · Choose the method

Validated binary or probabilistic evaluation; replicates if justified

5 · Report responsibly

Record observed results, assumptions, limitations and evidential weight

Original Simply Forensic workflow infographic. Apply each step under the laboratory’s approved SOP and relevant validation. The order is conceptual; some checks are iterative.

Practical troubleshooting: what should be checked first?

ObservationPossible explanationWhat should not be assumed
Strong peak imbalanceStochastic sampling, mixture effects, inhibition or locus-specific amplificationLow PHR always proves a mixture
One allele seen at a locusTrue homozygosity or undetected sister alleleA single detected peak always proves a homozygote
No qualifying peaks at a locusLocus dropout, degradation, inhibition or analytical failureThe donor genetically lacks the locus
Unexpected isolated peakMinor contributor, drop-in, contamination or artefactEvery unexplained peak is laboratory contamination
High shared peak in a mixtureMultiple allele contributions or stutter overlapEntire observed height belongs to one contributor
Replicate profiles differStochastic sampling, intermittent detection or other variationOne replicate must be incorrect
Repeated assay-specific null allelePrimer-binding variant or other locus-specific effectLow quantity must be the cause

Interpretation should start with analytical acceptability: control outcomes, peak morphology, dye cross-talk, stutter, baseline and sizing. Then examine DNA quantity/quality and variation across informative loci. Only after considering the plausible source number and missing information should an analyst decide on a binary or probabilistic comparison framework. These steps are not interchangeable with tailoring the interpretation to match a person of interest.

Validation, contamination and laboratory-specific decision rules

A laboratory should determine the performance of its assays and interpretation methods using validation samples that include relevant low-template DNA quantities, heterozygous profiles, mixtures, multiple contributor proportions, degraded material, possible inhibition and analytical artefacts. For a PG system, validation also needs to cover appropriate contributor numbers and parameters, convergence or other diagnostics, and performance on known-contributor data of similar complexity.

The FBI Quality Assurance Standards for Forensic DNA Testing Laboratories, effective July 1, 2025, apply within their defined US forensic DNA laboratory scope. SWGDAM interpretation documents and ISFG DNA Commission papers provide scientific guidance rather than automatically binding legislation in every country. Their terminology should not be substituted for a laboratory’s approved method without appropriate validation and authority.

An unexpected low-level peak cannot be labelled “drop-in from contamination” simply because it does not match a known genotype. Contamination may enter during collection, storage, extraction or later processing, while apparently extraneous alleles can have other explanations. Examine relevant negative controls, handling history and full-profile information; a clean negative control does not prove that all extraneous DNA sources were excluded. Refer to the STR artefacts troubleshooting guide for differentiating unexpected signals.

How should low-template uncertainty be reported?

Casework wording must reflect what was observed, which alternatives were evaluated and which interpretations are supported under the laboratory’s validated method. A qualified example for a DNA profile that exhibits stochastic behaviour is:

“The DNA profile exhibits features consistent with limited template information, including heterozygote peak-height imbalance and possible allelic dropout. The profile was evaluated in accordance with the laboratory’s validated interpretation procedure.”

For a suitable probabilistic evaluation, a report might explain that the LR incorporates uncertainty in genotype possibilities and stochastic effects under the propositions stated. That does not establish when or how DNA was transferred, nor does a positive LR mean the alleged activity occurred. Reporting language and statistical obligations differ by jurisdiction and laboratory; these are educational examples, not approved report templates.

Remember the difference between a possible undetected allele and a known allele: only a sample of known genotype, or other validated supporting evidence, can establish which allele was missing with sufficient confidence. When a specific comparison is unsupported, the scientifically defensible outcome may be inconclusive.

Common misconceptions about low-template forensic DNA

ClaimScientific correction
All samples below 100 pg are low-template, and all above are notNo universal molecular threshold separates stochastic from non-stochastic results
A low PHR proves a second contributorImbalance may occur within a genuine single-source heterozygote
A peak above ST rules out dropoutNot universally, and particularly not for shared peaks in mixtures
One observed allele proves homozygosityThe partner may have failed the assay’s detection criterion
Repeating PCR always improves a scarce sampleSplitting an extract can further limit molecules per amplification
Consensus profiles capture every genuine alleleSome genuine alleles fail to reproduce and can be excluded by a strict rule
Probabilistic genotyping reveals the true genotypes with certaintyIt evaluates propositions and uncertainty using a validated model

Key terms and definitions

Allelic dropout: failure to obtain a qualifying detected signal from an allele actually present. Locus dropout: non-detection of all alleles from a contributor at a locus. Peak-height ratio (PHR): lower divided by higher heterozygote peak height, expressed as a percentage. Stochastic effect: random variation in molecular sampling and amplification. Low-template DNA: DNA for which limited effective template makes stochastic variation consequential for interpretation. Consensus profile: result derived from independently tested amplifications using a defined reproducibility rule. Composite profile: a more inclusive combined representation of alleles from several analyses. Probabilistic genotyping: statistical evaluation of genotype possibilities and observed data under specified propositions.

Frequently asked questions

What is allelic dropout in forensic DNA profiling?

It is the failure of an allele actually present in a sample to generate a qualifying detected signal. In casework with unknown genotypes, the analyst usually evaluates possible dropout rather than directly observing which allele was lost.

Does a low PHR prove a DNA mixture?

No. Limited template and other amplification effects can create severe heterozygote imbalance in a single-source profile. Mixture assessment must consider the overall multi-locus data and validated criteria.

Is low-template DNA defined as less than 100 pg?

No universal amount defines every low-template profile. The influence of stochastic sampling depends on effective template molecules, sample condition, assay and analytical settings.

Can allelic dropout occur above a stochastic threshold?

A validated binary stochastic threshold does not guarantee a zero dropout probability. It is especially unsafe to apply a total composite mixture peak as if it represented one contributor’s allele.

Do repeated PCR amplifications fix low-template DNA profiles?

Not necessarily. Replicates can show variable detection and help evaluate uncertainty, but using multiple aliquots may reduce the molecules in each reaction. The laboratory must validate when replication is informative.

What is the difference between consensus and composite profiles?

Consensus approaches retain alleles meeting a defined reproducibility rule; composite approaches combine detected information more inclusively. Each may lose or retain different kinds of information and must be validated for its intended use.

Does probabilistic genotyping eliminate allelic dropout uncertainty?

No. It models uncertain data and genotype possibilities using validated parameters. Results remain conditional on propositions, analytical quality, chosen models and the laboratory’s validation scope.

Scientific references and further reading

View scientific references (14)
  1. Butler JM, Iyer H, Press R, Taylor MK, Vallone PM, Willis S. DNA Mixture Interpretation: A NIST Scientific Foundation Review. NIST IR 8351. 2024.
  2. SWGDAM. Interpretation Guidelines for Autosomal STR Typing by Forensic DNA Testing Laboratories. Revised July 13, 2021.
  3. SWGDAM. Guidelines for the Use of Probabilistic Genotyping with Autosomal STR Typing Results. Approved April 11, 2025.
  4. Federal Bureau of Investigation. Quality Assurance Standards for Forensic DNA Testing Laboratories. Effective July 1, 2025.
  5. Gill P, Whitaker J, Flaxman C, Brown N, Buckleton J. An investigation of the rigor of interpretation rules for STRs derived from less than 100 pg of DNA. Forensic Sci Int. 2000;112:17–40.
  6. Balding DJ, Buckleton J. Interpreting low template DNA profiles. Forensic Sci Int Genet. 2009;4:1–10.
  7. Gill P, Buckleton J. A universal strategy to interpret DNA profiles that does not require a definition of low-copy-number. Forensic Sci Int Genet. 2010;4:221–227.
  8. Kelly H, Bright JA, Curran JM, Buckleton J. Modelling heterozygote balance in forensic DNA profiles. Forensic Sci Int Genet. 2012;6:729–734.
  9. Timken MD et al. Stochastic sampling effects in STR typing: Implications for analysis and interpretation. Forensic Sci Int Genet. 2014;11:195–204.
  10. Gill P et al. DNA commission of the International Society of Forensic Genetics: Recommendations on the evaluation of STR typing results that may include drop-out and/or drop-in using probabilistic methods. Forensic Sci Int Genet. 2012;6:679–688.
  11. Cowen S, Debenham P, Dixon A, Kutranov S, Thomson J, Way K. An investigation of the robustness of the consensus method of interpreting low-template DNA profiles. Forensic Sci Int Genet. 2011;5:400–406.
  12. Gittelson S, Steffen CR, Coble MD. Low-template DNA: A single DNA analysis or two replicates? Forensic Sci Int. 2016;264:139–145.
  13. Steele CD, Greenhalgh M, Balding DJ. Evaluation of low-template DNA profiles using peak heights. Stat Appl Genet Mol Biol. 2016;15:431–445.
  14. Haned H, Gill P, Lohmueller K, Inman K, Rudin N. Validation of probabilistic genotyping software for use in forensic DNA casework: Definitions and illustrations. Science & Justice. 2016.
Share This Article
Follow:
Forensic Analyst by Profession. With Simplyforensic.com striving to provide a one-stop-all-in-one platform with accessible, reliable, and media-rich content related to forensic science. Education background in B.Sc.Biotechnology and Master of Science in forensic science.
Leave a Comment